Internal medicine physicians' perception of frequency and impact of corticosteroid-induced adverse events;Perception par les médecins internistes de la fréquence et de la gêne induite par les effets indésirables d'une corticothérapie systémique prolongée

Revue de Medecine Interne

Volumn 30, Issue 2, 2009, Pages 113-118

  Fardet, L ^a,b   Blanchon, T ^b   Perdoncini Roux, A ^a   Kettaneh, A ^a   Tiev, K ^a   Turbelin, C ^b   Dorleans, Y ^b   Cabane, J ^a   Hanslik, T ^b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Adverse events; Corticosteroids

Indexed keywords

CORTICOSTEROID;

ARTICLE; HORMONAL THERAPY; HUMAN; INSOMNIA; LIPODYSTROPHY; MEDICAL SOCIETY; PERCEPTION; PHYSICIAN; QUESTIONNAIRE; SKIN DISEASE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADRENAL CORTEX HORMONES; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HUMANS; INTERNAL MEDICINE; MALE; MIDDLE AGED; PHYSICIANS; QUESTIONNAIRES;

EID: 58649095888     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.08.004     Document Type: Article

References (23)

1. van Staa T.P., Leufkens H.G., Abenhaim L., Begaud B., Zhang B., and Cooper C. Use of oral corticosteroids in the United Kingdom. QJM 93 (2000) 105-111
2. Walsh L.J., Wong C.A., Pringle M., and Tattersfield A.E. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313 (1996) 344-346
3. Fardet L., Kassar A., Cabane J., and Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf 30 (2007) 861-881
4. Covar R.A., Leung D.Y., McCormick D., Steelman J., Zeitler P., and Spahn J.D. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J Allergy Clin Immunol 106 (2000) 651-659
5. Gabriel S.E., Sunku J., Salvarani C., O'Fallon W.M., and Hunder G.G. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 40 (1997) 1873-1878
6. Morrison E., Crosbie D., and Capell H.A. Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology (Oxford) 42 (2003) 1247-1250
7. Cullen G., Kelly E., and Murray F.E. Patients' knowledge of adverse reactions to current medications. Br J Clin Pharmacol 62 (2006) 232-236
8. Fardet L., Flahault A., Kettaneh A., Tiev K.P., Généreau T., Tolédano C., et al. Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion. Br J Dermatol 157 (2007) 142-148
9. Boston Collaborative Drug Study. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972;13:694-8.
10. Bolanos S.H., Khan D.A., Hanczyc M., Bauer M.S., Dhanani N., and Brown E.S. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol 92 (2004) 500-505
11. Brown E.S., Khan D.A., and Nejtek V.A. The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol 83 6 Pt 1 (1999) 495-503
12. Klein J.F. Adverse psychiatric effects of systemic glucocorticoid therapy. Am Fam Physician 46 (1992) 1469-1474
13. Kayani S., and Shannon D.C. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest 122 (2002) 624-628
14. Lambert M., Conus P., Eide P., Mass R., Karow A., Moritz S., et al. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 19 (2004) 415-422
15. George J., Munro K., McCaig D.J., and Stewart D.C. Prescription medications: beliefs, experiences, behavior, and adherence of sheltered housing residents. Ann Pharmacother 40 (2006) 2123-2129
16. Sodergard B., Halvarsson M., Tully M.P., Mindouri S., Nordstrom M.L., Lindback S., et al. Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther 31 (2006) 605-616
17. Barr R.G., Somers S.C., Speizer F.E., Camargo Jr. C.A., and National Asthma Education and Prevention Program (NAEPP). Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 12-26 162 (2002) 1761-1768
18. Shea S., Misra D., Ehrlich M.H., Field L., and Francis C.K. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health 82 (1992) 1607-1612
19. Lowry K.P., Dudley T.K., Oddone E.Z., and Bosworth H.B. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 39 7-8 (2005) 1198-1203
20. Nelson M.R., Reid C.M., Ryan P., Willson K., and Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust 185 (2006) 487-489
21. Heath K.V., Singer J., O'Shaughnessy M.V., Montaner J.S., and Hogg R.S. Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. J Acquir Immune Defic Syndr 31 (2002) 211-217
22. Turbi C., Herrero-Beaumont G., Acebes J.C., Torrijos A., Grana J., Miguelez R., et al. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clin Ther 26 (2004) 245-256
23. Sullivan P.S., Campsmith M.L., Nakamura G.V., Begley E.B., Schulden J., and Nakashima A.K. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS ONE 2 (2007) e552